The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with Alzheimer's Disease and clinical outcomes?
Autologous Adipose-derived Stromal Vascular Fraction (AD-SVF) will be infused intra-venous and Intra nasal. The therapy is composed of cells derived from a patients' own adipose tissue that are isolated within approximately 1 hour and immediately delivered back to the patient.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Procedure will be performed via liposuction to harvest Adipose-derived stromal vascular fraction cells.
IV and Intranasal Infusion of isolated AD-SVF
Ageless Regenerative Institute LLC
Aventura, Florida, United States
Clinical Improvement in Mini Mental State Examination (MMSE)
Improvement in MMSE six months after therapy
Time frame: Six months after therapy
Adverse Event
The safety of adipose-derived stem cell injection will be evaluated by assessment of the frequency and nature of adverse events occurring during the study injection and up to the 12-months period following treatment.
Time frame: One year after stem cell therapy
Clinical Improvement in Functional Activities Questionnaire (FAQ)
Time frame: Three and six months after therapy
Clinical Improvement in Activities of Daily Living Questionnaire (ADL)
Time frame: Three and six months after therapy
Clinical Improvement in Geriatric Depression Scale (GDS)
Time frame: Three and six months after therapy
Clinical Improvement in Mini Mental State Examination (MMSE)
Time frame: Three months after therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.